3.97
0.25%
-0.010
Finanzdaten der Senti Biosciences Inc-Aktie (SNTI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | 0.338 | 0.937 | 1.286 |
Operating Expenses
|
12.82%
16.30
|
18.70 | 44.21 | 20.57 | 21.12 |
Operating Income/Loss |
12.82%
-16.30
|
-18.70 | -43.88 | -19.64 | -19.83 |
Nonoperating Income/Loss |
41,800%
4.19
|
0.01 | 7.261 | 0.938 | 1.112 |
Income/Loss From Continuing Operations Before Tax |
85.48%
-12.11
|
-83.41 | -36.62 | -18.70 | -18.72 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
85.48%
-12.11
|
-83.41 | -36.62 | -18.70 | -18.72 |
Income/Loss From Discontinued Operations, Net Of Tax |
100.00%
-
|
12.35 | 21.69 | - | - |
Net Income/Loss
|
82.96%
-12.11
|
-71.06 | -14.92 | -18.70 | -18.72 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
47,275%
45.71
|
0.0965 | 44.47 | 44.28 | 44.07 |
Diluted Average Shares |
47,275%
45.71
|
0.0965 | 44.47 | 44.28 | 44.07 |
Basic Earnings Per Share |
38.10%
-0.26
|
-0.42 | -0.34 | -0.42 | -0.42 |
Diluted Earnings Per Share |
38.10%
-0.26
|
-0.42 | -0.34 | -0.42 | -0.42 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):